IFF Health, Shanghai has sealed a strategic partnership for R&D of anti-aging ingredients with By-Health, a Chinese maker of dietary supplements and raw materials.
Under the partnership, both companies will research on the production and international development of science-based anti-aging ingredient formulations. The formulations will have a focus on fighting cellular oxidative stress, support of intracellular health such as of the mitochondria, and telomerase research.
Particularly on telomeres, they are the repetitive nucleotide sequences that cap chromosomes and protect them from deterioration or from fusing with neighbouring chromosomes and preventing healthy cell replication and turnover. The companies have identified telomeres as being key factors in the process of aging.
The collaboration will also see IFF Health and By-Health teams investigate ingredient synergies that will not only be marked by high efficiency but also applicability to better-for-you food and beverage applications.
Raimund Hoenes, general manager of IFF Health, commented: “By-Health’s focus on innovative R&D matches our commitment to quality, safety, science and innovation. We’re honoured to partner with By-Health and look forward to a fruitful collaboration.”
